Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Mihić Lasan, Irena"'
Autor:
Skoko, Marija, Mihić Lasan, Irena, Bilić, Karmen, Štefić, Anita, Jularić, Anamarija, Dodig, Javorka, Bošnjak, Tomislav, Misir Šitum, Stanka, Brozović, Gordana, Vrdoljak, Danko Velimir, Mihaljević, Mihaela, Vučemilo, Tiha, Marinković Strumberger, Tara
Background : In the past, chirrotic patients were usually consid-ered as patients with high risk of bleeding and hipocoagulability. The common practice was to correct coagulation parameters with plasma products and platelet. Cirrhosis is characterize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::74f70f0ab27589f402c405b8da8c365d
https://doi.org/10.1002/rth2.12589
https://doi.org/10.1002/rth2.12589
BACKGROUND: Prothrombin time (PT) and activated partial thromboplastin time (aPTT) are global coagulation tests for diagnosis of coagulation disorders and therapy management. PT expressed as INR is used to monitor warfarin therapy whose desirable val
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::4db05dc4058b53771bd7e3a253cefd65
https://www.bib.irb.hr/882365
https://www.bib.irb.hr/882365
Autor:
Skoko, Marija, Mihić-Lasan, Irena, Culej, Jelena, Krajačić-Karas, Gorana, Vučemilo, Tiha, Šturm, Deana
Publikováno v:
Libri Oncologici : Croatian Journal of Oncology
Volume 40
Issue 1-3
Volume 40
Issue 1-3
Ferritin is a positive acute phase reactant. It is produced and secreted by various cells such as hepatocytes, macrophages and cancer cells. This was a retrospective study which included 46 patients with solid tumors who were tested for ferritin leve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::852b4d9fbcdb06feb4f7d1314efa350d
https://www.bib.irb.hr/713492
https://www.bib.irb.hr/713492
Autor:
Culej, Jelena, Mihić Lasan, Irena, Skoko, Marija, Krajačić Karas, Gorana, Vučemilo, Tiha, Šturm, Deana
Standard coagulation tests are plasma based and do not give complete information about coagulation in vivo. Thrombelastography is a test which allows coagulation testing in whole blood. It is useful in perioperative management of bleeding patients an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::c6b1768e8e9a629adc65e1bfca7d95a9
https://www.bib.irb.hr/713588
https://www.bib.irb.hr/713588
Autor:
Mihić-Lasan, Irena, Skoko, Marija, Culej, Jelena, Vučemilo, Tiha, Krajačić-Karas, Gorana, Šturm, Deana
Publikováno v:
Libri Oncologici : Croatian Journal of Oncology
Volume 40
Issue 1-3
Volume 40
Issue 1-3
Cancer patients have a four-fold increased risk of developing venous thromboembolism (VTE), relative to the general population. Affecting about 15 % of patients with cancer, it is presenting a great challenge for prophylaxis and treatment. The standa
Autor:
Mihić-Lasan, Irena, Penavić, Ivan, Sorić, Krunoslava, Skoko, Marija, Culej, Jelena, Vučemilo, Tiha, Šturm, Deana
Publikováno v:
Libri Oncologici : Croatian Journal of Oncology
Volume 40
Issue 1-3
Volume 40
Issue 1-3
The presence of haematoma in patients after surgery is associated with increased plasmatic fibrinolytic activity. D-dimer is a specific marker of coagulation activation and fibrinolysis and, therefore, an indirect marker of thrombotic activity. The p
Publikováno v:
Libri Oncologici : Croatian Journal of Oncology
Volume 40
Issue 1-3
Volume 40
Issue 1-3
Upper extremity deep venous thrombosis (UEDVT) makes approximately 4% to 20% of all venous thromboembolism (VTE). Cancer is the most relevant acquired thrombotic risk factor of VTE, because of its myriad of prothrombotic molecules released by neoplas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::955ed3ef800439901e1bdec76479f280
https://www.bib.irb.hr/713599
https://www.bib.irb.hr/713599
Publikováno v:
Libri Oncologici : Croatian Journal of Oncology
Volume 39
Issue 1-3
Volume 39
Issue 1-3
Vein thrombosis is a common complication in patients with cancer. Tumor cells produce or have expressed on their surface many procoagulant factors such as tissue factor and cancer procoagulant. Besides procoagulant activity of the tumor cells, surgic
The study is a retrospective review of 407 female patients with primary breast cancer and 320 female patients with benign breast changes who were surgically treated in the University Hospital for Tumors during calendar year 2009. We investigated a po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::209b8affb683c93a5b86f7c2e647156d
https://www.bib.irb.hr/689691
https://www.bib.irb.hr/689691
Publikováno v:
Libri Oncologici : Croatian Journal of Oncology
Volume 39
Issue 1-3
Volume 39
Issue 1-3
The study is a retrospective review of 407 female patients with primary breast cancer and 320 female patients with benign breast changes who were surgically treated in the University Hospital for Tumors during calendar year 2009. We investigated a po